Exploring the risk of second primary malignancies in laryngeal cancer survivors: insights from the SEER database
European Archives of Oto-Rhino-Laryngology · 2024-08 · 281 (8) · 4409-4417
DOI: 10.1007/s00405-024-08731-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Archives of Oto-Rhino-Laryngology, online erschienen am 22.05.2024. Verfasst von Abdelrahman Yousry Afify und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, New Giza University (NGU), Giza, Egypt. aafify@ngu.edu.eg. Hauptthemen laut MEDLINE: Neoplasms, Second Primary, Laryngeal Neoplasms, SEER Program, Cancer Survivors. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: New Giza University.
Abstract (Originalsprache)
Purpose
We intended to investigate the risk for second primary malignancy (SPM) development in Laryngeal Cancer (LC) survivors. We conducted a population-based analysis of SPM risk using the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) database.
Methods
Data of selected LC survivors from the SEER database between 2000 and 2020 were examined. Standardized Incidence ratios (SIRs) for SPM development were calculated, followed by detailed stratification according to anatomical site and different latency periods.
Results
A total of 8413 SPMs were observed in our extracted cohort. The collective standardized incidence of SPMs was 2.12 (95% CI 2.07–2.17) compared to the US population, with an absolute excess risk (AER) of 201.73 per 10,000 individuals. The highest SPM risks were observed in patients with young age at diagnosis, females, and American Indians/Alaska natives. Increased SPM risks were reported in patients receiving all modalities of treatment including surgery, chemotherapy, and radiotherapy. Most SPMs were detected in solid organs such as the lungs and bronchus, oral cavity and pharynx, and prostate. The highest increased risks of developing SPMs were observed in Trachea, larynx, oral cavity and pharynx, lung and bronchus, and esophagus.
Conclusions
The risk of SPMs in LC survivors was significantly increased compared to the general US population. Accordingly, a more impactful cancer surveillance strategy for LC patients should be implemented.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, New Giza University (NGU), Giza, Egypt. aafify@ngu.edu.eg.
- School of Medicine, New Giza University (NGU), Giza, Egypt.
- Medical Research Platform, Cairo, Egypt.
Förderung
- New Giza University
Zitieren
APA
Afify, A. Y., & Ashry, M. H. (2024). Exploring the risk of second primary malignancies in laryngeal cancer survivors: insights from the SEER database. European Archives of Oto-Rhino-Laryngology, 281(8), 4409-4417. https://doi.org/10.1007/s00405-024-08731-9
Vancouver
Afify AY, Ashry MH. Exploring the risk of second primary malignancies in laryngeal cancer survivors: insights from the SEER database. European Archives of Oto-Rhino-Laryngology. 2024;281(8):4409-4417. doi:10.1007/s00405-024-08731-9
BibTeX
@article{Afify2024,
author = {Afify, Abdelrahman Yousry and Ashry, Mohamed Hady},
title = {Exploring the risk of second primary malignancies in laryngeal cancer survivors: insights from the SEER database},
journal = {European Archives of Oto-Rhino-Laryngology},
year = {2024},
volume = {281},
number = {8},
pages = {4409--4417},
doi = {10.1007/s00405-024-08731-9}
}
EUVIMED